PMID: 9434686Jan 22, 1998Paper

Experience with living-donor lobar transplantation for indications other than cystic fibrosis

The Journal of Thoracic and Cardiovascular Surgery
Vaughn A StarnesWinfield J Wells

Abstract

Since development of a living donor bilateral lobar transplantation protocol for patients with cystic fibrosis, our indications have expanded to include recipients with other diagnoses. We report on our experience in eight patients with primary pulmonary hypertension, postchemotherapy pulmonary fibrosis, bronchopulmonary dysplasia, idiopathic pulmonary fibrosis, and obliterative bronchiolitis. The average age of the eight patients was 19.1 years (range 9 to 40). The mean preoperative carbon dioxide tension for the four patients who did not have primary pulmonary hypertension was 92 mm Hg (range 64 to 120 mm Hg), and the two patients with pulmonary fibrosis were intubated (one on high-frequency jet ventilation). Each recipient received a right lower lobe (n = 7) or middle lobe (n = 1) and a left lower lobe (n = 8) from a total of 16 donors representing various combinations of the recipient's family (n = 15) and an unrelated friend (n = 1). With an average follow-up of 1 year the overall survival is 75%. For the five patients followed up for at least 1 year, mean forced vital capacity was 80.6%, forced expiratory volume in 1 second was 75.6%, mid-forced expiratory flow was 64%, and diffusing lung capacity corrected for alveolar v...Continue Reading

Associated Clinical Trials

References

Nov 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·V A StarnesF A Schenkel

❮ Previous
Next ❯

Citations

Jan 6, 2001·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·K UedaN Shimizu
Jan 31, 2004·The Journal of Thoracic and Cardiovascular Surgery·Vaughn A StarnesMark L Barr
Aug 21, 2003·The Journal of Thoracic and Cardiovascular Surgery·Hiroshi DateNobuyoshi Shimizu
Dec 26, 2001·Transplantation Proceedings·M L BarrV A Starnes
Sep 2, 1998·Transplantation Proceedings·M L BarrV A Starnes
Apr 8, 1999·The New England Journal of Medicine·S M Arcasoy, R M Kotloff
Oct 5, 2001·Current Opinion in Pulmonary Medicine·R SulicaM L Padilla
Aug 12, 2005·Current Opinion in Pulmonary Medicine·Raed AlalawiTony N Hodges
May 14, 2005·Current Opinion in Pediatrics·Erika Berman Rosenzweig, Robyn J Barst
Jul 31, 2003·American Journal of Respiratory and Critical Care Medicine·Julian AllenUNKNOWN American Thoracic Society
Apr 2, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Kengo Fukushima KusanoTohru Ohe
Jul 22, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R D YusenUNKNOWN RELIVE Study Group
Sep 19, 2003·Chest Surgery Clinics of North America·Michael E BowdishVaughn A Starnes
Mar 1, 2005·The Annals of Thoracic Surgery·Yoshifumi SanoNobuyoshi Shimizu
Oct 24, 2000·The Journal of Thoracic and Cardiovascular Surgery·R J BattafaranoG A Patterson
Dec 2, 2004·The Journal of Thoracic and Cardiovascular Surgery·Hiroshi DateNobuyoshi Shimizu
Feb 1, 2005·The Annals of Thoracic Surgery·Michael E BowdishMark L Barr
Nov 27, 2004·Clinics in Chest Medicine·Brandon S Lu, Sangeeta M Bhorade
Oct 3, 2001·The Journal of Thoracic and Cardiovascular Surgery·H DateN Shimizu
Mar 20, 2004·Pediatric Pulmonology. Supplement·Marlyn S Woo
Jun 2, 2004·Pediatric Pulmonology·Erika Berman RosenzweigRobyn J Barst
Jul 23, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Michael E BowdishVaughn A Starnes
Aug 5, 2008·The Medical Journal of Australia·Dominic T KeatingGregory I Snell
Sep 15, 2004·Journal of Cardiothoracic and Vascular Anesthesia·Cornelis VeekenKatherine P Grichnik
Sep 19, 2003·Chest Surgery Clinics of North America·Clemens AignerWalter Klepetko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Thoracic and Cardiovascular Surgery
Vaughn A StarnesFelicia A Schenkel
The Journal of Thoracic and Cardiovascular Surgery
Hiroshi DateNobuyoshi Shimizu
World Journal of Surgery
R G Cohen, Vaughn A Starnes
© 2021 Meta ULC. All rights reserved